Serum from rats fed red or yellow tomatoes induces Connexin43 expression independently from lycopene in a prostate cancer cell line

Biochemical and Biophysical Research Communications

Volumn 364, Issue 3, 2007, Pages 578-582

  Gitenay, Delphine ^a   Lyan, Bernard ^a   Talvas, Jérémie ^a   Mazur, Andrzej ^a   Georgé, Stéphane ^b   Caris Veyrat, Catherine ^c   Rock, Edmond ^a  

^a INRA and University of Auvergne   (France)

^b Centre Technique de la Conservation et des Produits Agricoles (CTCPA)   (France)

^c UNIVERSITY OF AVIGNON   (France)

Author keywords

Connexin43; Lycopene; PC3AR cells; Serum; Tomato

Indexed keywords

CONNEXIN 43; LYCOPENE;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS REGULATION; RAT; TOMATO; UPREGULATION;

ANIMALS; CAROTENOIDS; CELL LINE, TUMOR; CONNEXIN 43; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; LYCOPERSICON ESCULENTUM; MALE; PLANT EXTRACTS; PROSTATIC NEOPLASMS; RATS; SERUM; UP-REGULATION;

LYCOPERSICON ESCULENTUM; RATTUS;

EID: 35648931498     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.030     Document Type: Article

References (36)

1. Giovannucci E., Ascherio A., Rimm E.B., Stampfer M.J., Colditz G.A., and Willett W.C. Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl. Cancer Inst. 87 (1995) 1767-1776
2. Giovannucci E., and Clinton S.K. Tomatoes, lycopene, and prostate cancer. Proc. Soc. Exp. Biol. Med. 218 (1998) 129-139
3. Tzonou A., Signorello L.B., Lagiou P., Wuu J., Trichopoulos D., and Trichopoulou A. Diet and cancer of the prostate: a case-control study in Greece. Int. J. Cancer 80 (1999) 704-708
4. Di Mascio P., Kaiser S., and Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys. 274 (1989) 532-538
5. Lu Q.Y., Hung J.C., Heber D., Go V.L., Reuter V.E., Cordon-Cardo C., Scher H.I., Marshall J.R., and Zhang Z.F. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol. Biomark. Prev. 10 (2001) 749-756
6. Wu K., Erdman Jr. J.W., Schwartz S.J., Platz E.A., Leitzmann M., Clinton S.K., DeGroff V., Willett W.C., and Giovannucci E. Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol. Biomark. Prev. 13 (2004) 260-269
7. McMillan D.C., Talwar D., Sattar N., Underwood M., O'Reilly D.S., and McArdle C. The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. Clin. Nutr. 21 (2002) 161-164
8. Hantz H.L., Young L.F., and Martin K.R. Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells. Exp. Biol. Med. (Maywood) 230 (2005) 171-179
9. Hwang E.S., and Bowen P.E. Effects of lycopene and tomato paste extracts on DNA and lipid oxidation in LNCaP human prostate cancer cells. Biofactors 23 (2005) 97-105
10. Hwang E.S., and Bowen P.E. Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. J. Med. Food 7 (2004) 284-289
11. Kotake-Nara E., Kushiro M., Zhang H., Sugawara T., Miyashita K., and Nagao A. Carotenoids affect proliferation of human prostate cancer cells. J. Nutr. 131 (2001) 3303-3306
12. Obermuller-Jevic U.C., Olano-Martin E., Corbacho A.M., Eiserich J.P., van der Vliet A., Valacchi G., Cross C.E., and Packer L. Lycopene inhibits the growth of normal human prostate epithelial cells in vitro. J. Nutr. 133 (2003) 3356-3360
13. Pastori M., Pfander H., Boscoboinik D., and Azzi A. Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells. Biochem. Biophys. Res. Commun. 250 (1998) 582-585
14. Aust O., Ale-Agha N., Zhang L., Wollersen H., Sies H., and Stahl W. Lycopene oxidation product enhances gap junctional communication. Food Chem. Toxicol. 41 (2003) 1399-1407
15. Chalabi N., Delort L., Satih S., Dechelotte P., Bignon Y.J., and Bernard-Gallon D.J. Immunohistochemical expression of RAR{alpha}, RAR{beta}, and Cx43 in breast tumor cell lines after treatment with lycopene and correlation with RT-QPCR. J. Histochem. Cytochem. (2007)
16. Chalabi N., Le Corre L., Maurizis J.C., Bignon Y.J., and Bernard-Gallon D.J. The effects of lycopene on the proliferation of human breast cells and BRCA1 and BRCA2 gene expression. Eur. J. Cancer 40 (2004) 1768-1775
17. Fornelli F., Leone A., Verdesca I., Minervini F., and Zacheo G. The influence of lycopene on the proliferation of human breast cell line (MCF-7). Toxicol. In Vitro 21 (2007) 217-223
18. Nahum A., Hirsch K., Danilenko M., Watts C.K., Prall O.W., Levy J., and Sharoni Y. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Oncogene 20 (2001) 3428-3436
19. Nahum A., Zeller L., Danilenko M., Prall O.W., Watts C.K., Sutherland R.L., Levy J., and Sharoni Y. Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1. Eur. J. Nutr. 45 (2006) 275-282
20. Palozza P., Sheriff A., Serini S., Boninsegna A., Maggiano N., Ranelletti F.O., Calviello G., and Cittadini A. Lycopene induces apoptosis in immortalized fibroblasts exposed to tobacco smoke condensate through arresting cell cycle and down-regulating cyclin D1, pAKT and pBad. Apoptosis 10 (2005) 1445-1456
21. Park Y.O., Hwang E.S., and Moon T.W. The effect of lycopene on cell growth and oxidative DNA damage of Hep3B human hepatoma cells. Biofactors 23 (2005) 129-139
22. Bertram J.S. Dietary carotenoids, connexins and cancer: what is the connection?. Biochem. Soc. Trans. 32 (2004) 985-989
23. Trosko J.E., and Chang C.C. Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer. Mutat. Res. 480-481 (2001) 219-229
24. Livny O., Kaplan I., Reifen R., Polak-Charcon S., Madar Z., and Schwartz B. Oral cancer cells differ from normal oral epithelial cells in tissue like organization and in response to lycopene treatment: an organotypic cell culture study. Nutr. Cancer 47 (2003) 195-209
25. Chen L., Stacewicz-Sapuntzakis M., Duncan C., Sharifi R., Ghosh L., van Breemen R., Ashton D., and Bowen P.E. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J. Natl. Cancer Inst. 93 (2001) 1872-1879
26. Kucuk O., Sarkar F.H., Djuric Z., Sakr W., Pollak M.N., Khachik F., Banerjee M., Bertram J.S., and Wood Jr. D.P. Effects of lycopene supplementation in patients with localized prostate cancer. Exp. Biol. Med. (Maywood) 227 (2002) 881-885
27. Imaida K., Tamano S., Kato K., Ikeda Y., Asamoto M., Takahashi S., Nir Z., Murakoshi M., Nishino H., and Shirai T. Lack of chemopreventive effects of lycopene and curcumin on experimental rat prostate carcinogenesis. Carcinogenesis 22 (2001) 467-472
28. Boileau T.W., Liao Z., Kim S., Lemeshow S., Erdman Jr. J.W., and Clinton S.K. Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J. Natl. Cancer Inst. 95 (2003) 1578-1586
29. Canene-Adams K., Lindshield B.L., Wang S., Jeffery E.H., Clinton S.K., and Erdman Jr. J.W. Combinations of tomato and broccoli enhance antitumor activity in dunning r3327-h prostate adenocarcinomas. Cancer Res. 67 (2007) 836-843
30. Gann P.H., and Khachik F. Tomatoes or lycopene versus prostate cancer: is evolution anti-reductionist?. J. Natl. Cancer Inst. 95 (2003) 1563-1565
31. Livny O., Kaplan I., Reifen R., Polak-Charcon S., Madar Z., and Schwartz B. Lycopene inhibits proliferation and enhances gap-junction communication of KB-1 human oral tumor cells. J. Nutr. 132 (2002) 3754-3759
32. Clinton S.K., Emenhiser C., Schwartz S.J., Bostwick D.G., Williams A.W., Moore B.J., and Erdman Jr. J.W. cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol. Biomark. Prev. 5 (1996) 823-833
33. Lin C.Y., Huang C.S., and Hu M.L. The use of fetal bovine serum as delivery vehicle to improve the uptake and stability of lycopene in cell culture studies. Br. J. Nutr. 98 (2007) 226-232
34. Lindshield B.L., Canene-Adams K., and Erdman Jr. J.W. Lycopenoids: are lycopene metabolites bioactive?. Arch. Biochem. Biophys. 458 (2007) 136-140
35. Caris-Veyrat C., Schmid A., Carail M., and Bohm V. Cleavage products of lycopene produced by in vitro oxidations: characterization and mechanisms of formation. J. Agric. Food Chem. 51 (2003) 7318-7325
36. Ferreira A.L., Yeum K.J., Russell R.M., Krinsky N.I., and Tang G. Enzymatic and oxidative metabolites of lycopene. J. Nutr. Biochem. 14 (2003) 531-540